Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00254319
Title Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Cooper Health System
Indications

lung non-small cell carcinoma

Therapies

Carboplatin

Bevacizumab + Pemetrexed Disodium

Age Groups: adult
Covered Countries USA


No variant requirements are available.